Adamantane

Adamantane

SCHEMBL4444785

C1C2CC3CC1CC(C2)C3.Oc1ccccc1.Oc1ccccc1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.65
CA2 P00918 3/20 0.65
CA9 Q16790 3/20 0.65
CA14 Q9ULX7 3/20 0.65
CA1 P00915 2/20 0.65
CA3 P07451 2/20 0.65
CA4 P22748 2/20 0.65
GLA P06280 1/20 0.65
TDP1 Q9NUW8 1/20 0.65
MMP3 P08254 1/20 0.46
BCL2L1 Q07817 1/20 0.46
ESR1 P03372 6/20 0.40
ESR2 Q92731 6/20 0.40
MEN1 O00255 2/20 0.40
NPC1 O15118 2/20 0.40
KMT2A Q03164 2/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
LTA4H P09960 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adamantane SCHEMBL5826202 1.00 CA12 (0.65) CA12CA2CA9CA14CA1
Adamantane SCHEMBL383968 1.00 CA12 (0.65) CA12CA2CA9CA14CA1
Adamantane SCHEMBL29166015 0.97 CA12 (0.61) CA12CA2CA9CA14CA1
Phenol SCHEMBL27766689 0.89 CA12 (0.58) CA12CA2CA9CA14CA1
Phenol SCHEMBL11852630 0.89 CA12 (0.58) CA12CA2CA9CA14CA1
Phenol SCHEMBL936069 0.81
Phenol SCHEMBL11316144 0.81 CA12 (0.85) CA12CA2CA9CA14CA1
Phenol SCHEMBL27899230 0.81 CA12 (0.85) CA12CA2CA9CA14CA1
Phenol SCHEMBL10974607 0.81 CA12 (0.85) CA12CA2CA9CA14CA1
Phenol SCHEMBL27535722 0.81 CA12 (0.85) CA12CA2CA9CA14CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137775-A1 ADAMANTANE DERIVATIVE, EPOXY RESIN, AND OPTICAL ELECTRONIC MEMBER USING RESIN COMPOSITION COMPRISING THEM IDEMITSU KOSAN CO., LTD. (JP) 2009-05-28 US disclosed
EP-1923416-A1 ADAMANTANE DERIVATIVE, EPOXY RESIN, AND OPTICAL ELECTRONIC MEMBER USING RESIN COMPOSITION COMPRISING THEM Idemitsu Kosan Co., Ltd. (JP) 2008-05-21 EP disclosed
JP-2007023019-A 1,3-BIS(3-FORMYL-4-HYDROXYPHENYL)ADAMANTANE AND POLYNUCLEAR POLYPHENOL DERIVED THEREFROM HONSHU CHEM IND CO LTD 2007-02-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137775-A1 ADAMANTANE DERIVATIVE, EPOXY RESIN, AND OPTICAL ELECTRONIC MEMBER USING RESIN COMPOSITION COMPRISING THEM ARCN1, MEP1A, EPN1 CA12 3541/4885CA2 4357/4885CA9 4317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.